A BRISTOL TENNESSEE PHARMACEUTICAL COMPANY WHO TEAMED UP WITH ANOTHER FIRM TO STUDY A NEW MEDICATION GEARED AT DETERRING PRESCRIPTION DRUG ABUSE, SEEMS TO BE HAPPY WITH THE RESULTS. KING PHARMACEUTICALS AND ACURA PLAN TO SUBMIT THE NEW DRUG FOR APPLICATION TO THE U.S. FOOD AND DRUG ADMINISTRATION FOR ACUROX TABLETS BY THE END OF THE YEAR. THE TWO COMPANIES ARE ALSO LOOKING AT APPROVAL OF ANOTHER PAIN KILLING DRUG. BOTH WERE DEVELOPED BY USING ACURA’S PATENTED AVERSION TECHNOLOGY. IF APPROVED, KING WILL MARKET AND SELL THE TWO NEW DRUGS.